Snackisode 5.2: Jean Valjean

Lauren and JJ investigate a case of lethargy, inappetence,
vomiting, and distended abdomen in a cat. This episode is part 2 of
2. This episode contains a detailed review of feline infectious
peritonitis (FIP). Resources: * Rothrock, K., & Brister, J.
(2024). Feline infectious peritonitis (feline). VINcyclopedia of
Diseases. www.vin.com * Coggins, S. J., et al. (2023). Outcomes of
treatment of cats with feline infectious peritonitis using
parenterally administered remdesivir, with or without transition to
orally administered GS-441524. Journal of Veterinary Internal
Medicine, 37(5), 1772-1783.
https://onlinelibrary.wiley.com/doi/10.1111/jvim.16803 * Taylor, S.
S., et al. (2023). Retrospective study and outcome of 307 cats with
feline infectious peritonitis treated with legally sourced
veterinary compounded preparations of remdesivir and GS-441524
(2020-2022). Journal of Feline Medicine and Surgery, 25(9).
https://journals.sagepub.com/doi/full/10.1177/1098612X231194460 *
Wogan, L. (2024). Confusion besets first legal FIP treatment in us
(updated). VIN News Service.
https://news.vin.com/default.aspx?pid=210&Id=11910939&sx=239128590&n=1&f5=1
* Wogan, L. (2024). Overdue good news arrives for FIP cats in the
US. VIN News Service.
https://news.vin.com/default.aspx?pid=210&Id=12090343&f5=1
* FIP Resources for Veterinarians. Stokes Pharmacy. Last accessed
November 19, 2024.
https://www.stokespharmacy.com/fip/veterinary-resources/ * Green,
J., et al. (2023). Thirty-two cats with effusive or non-effusive
feline infectious peritonitis treated with a combination of
remdesivir and GS-441524. Journal of Veterinary Internal Medicine,
37(5), 1784-1793.
https://onlinelibrary.wiley.com/doi/10.1111/jvim.16804 * Murphy, B.
G., et al. (2018). The nucleoside analog GS-441524 strongly
inhibits feline infectious peritonitis (FIP) virus in tissue
culture and experimental cat infection studies. Veterinary
Microbiology, 219(0), 226-233.
https://www.sciencedirect.com/science/article/pii/S0378113518301603?via%3Dihub
* Pedersen, N. C., et al. (2019). Efficacy and safety of the
nucleoside analog GS-441524 for treatment of cats with naturally
occurring feline infectious peritonitis. Journal of Feline Medicine
and Surgery, 21(4), 271-281.
https://journals.sagepub.com/doi/10.1177/1098612X19825701 * Kent,
A. M., et al. (2024). Unlicensed antiviral products used for the
at-home treatment of feline infectious peritonitis contain
GS-441524 at significantly different amounts than advertised.
Journal of the American Veterinary Medical Association, 262(4),
489-497.
https://avmajournals.avma.org/view/journals/javma/262/4/javma.23.08.0466.xml
* Allinder, M., et al. (2024). Uroliths composed of antiviral
compound GS-441524 in 2 cats undergoing treatment for feline
infectious peritonitis. Journal of Veterinary Internal Medicine,
38(1), 370-374.
https://onlinelibrary.wiley.com/doi/10.1111/jvim.16954 * United
States Food and Drug Administration. (2024). FDA announces position
on use of compounded GS-441524 to treat FIP. Last accessed November
19, 2024.
https://www.fda.gov/animal-veterinary/cvm-updates/fda-announces-position-use-compounded-gs-441524-treat-fip